Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

In this article we will help you to know more about the infusion therapy, about its process, precautions to be taken care ...

The Elder Scrolls IV: Oblivion Remake is not only real, but releasing soon. We know this from both extensive reporting and because information and media of the remake have leaked. Since then ...

For active, moderate-to-severe TED, there was a modest preference toward first-line treatment with teprotumumab among North American respondents (37%), whereas IV steroids were preferred among ...

Rumors of a ground-up remake of The Elder Scrolls IV: Oblivion have been swirling for years, but insiders are now claiming the release will happen at any moment this month. Skyrim is one of the ...

During Q1 2025, pharmaceutical companies accelerated biosimilar expansion through strategic acquisitions and partnerships in hopes of boosting patient access to lower-cost treatments in immunology and ...

Actemra, an IV monoclonal antibody that works somewhat differently and is also known by the generic name tocilizumab, was associated with infection and low white blood cell counts in some studies.

Therapeutic Use Exemptions (TUE) Physician Guidelines - on Intravenous Infusion. All TUE Physician Guidelines are reviewed annually by WADA's TUE Expert Advisory Group to ensure that they remain ...

The Elder Scrolls IV: Oblivion remake is reportedly helmed by Virtuous The Bethesda RPG is considered one of the greatest games of all time The Elder Scrolls IV: Oblivion remake has not been confirmed ...

More speculation continues to bubble in the rumor pot regarding the possibility that the Elder Scrolls IV: Oblivion remake is set for release in April - and it looks like the game could be out in ...